News | News By Subject | News by Disease News By Date | Search News

Cystic fibrosis News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Vertex (VRTX) Inks Deal Worth $250 Million for Concert Pharma (CNCE)'s Cystic Fibrosis Drug     3/6/2017
Anthera Pharma (ANTH) Plunges After Cystic Fibrosis Drug Fails Late-Stage Trial     12/29/2016
A Crucial Need for Symptomatic Treatments Still Exists for Cystic Fibrosis Patients     12/5/2016
After Hep C Flop, Has Vertex (VRTX) Learned From Its Past Mistakes?     10/18/2016
Pharma Bro Warned You: Mast Therapeutics (MSTX) Craters After Drug Flunks Phase III Test, Job Cuts Expected     9/22/2016
Vertex (VRTX) Dumps Phase III Cystic Fibrosis Study     8/17/2016
Vertex (VRTX) and Moderna Hammer Out $315 Million+ Deal to Treat Cystic Fibrosis Using mRNA Technology     7/6/2016
FDA Spurns Vertex (VRTX) Application for Expanded Use of Kalydeco     2/5/2016
How Vertex (VRTX)'s Long-Term $500K Gamble Paid Off with a $30 Billion Return     11/18/2015
Vertex (VRTX)'s Success Spurs Startups Corbus and Pulmatrix to Enter Cystic Fibrosis Market     8/18/2015
Watch Out Gilead (GILD), Investors Feel Vertex (VRTX) May Be Biogen (BIIB)'s Good Fit     8/4/2015
Vertex (VRTX) Gets FDA Approval for $259K Per Year CF Drug     7/7/2015
Vertex (VRTX) Poised to Become Profitable Following Expected FDA Approval of Orkambi     7/1/2015
Tiny Parion Sciences Wrangles Lung Pact Worth $1.2 Billion From Vertex (VRTX)     6/8/2015
Corbus Will Interview Twice as Many Candidates in 2015 as Its Ranks Grow     5/29/2015

News from Around the Web
New Life Form Discovered In Saliva Is Linked To Human Disease, University of Washington Study     6/27/2016
VisiVest, A New Connected High-Frequency Chest-Wall Oscillation System, Hill-Rom Reveals     6/22/2016
The Importance Of Implementing CF Newborn Screening Reinforced, McGill University Study     5/5/2016
Researchers Build Promising CF Diagnostic System Using Microsoft's Xbox Kinect Sensors     3/30/2016
Fast, Accurate Cystic Fibrosis Test Developed At Stanford University     2/2/2016
Why Investors Shouldn't Freak Out Over Vertex (VRTX)'s Latest Trial Results     3/24/2015
Garlic Could Help Cure Lung Infection, University of Edinburgh Study     2/25/2015
University of Pittsburgh-Led Study Suggests Cystic Fibrosis Is Two Diseases, One Doesn’t Affect Lungs     7/23/2014
Cystic Fibrosis And Diabetes Link Explained, Lund University Study     6/3/2014
New Drug Target Found for Cystic Fibrosis Lung Disease, BC Children's Hospital Study     11/8/2012
Sea Sponge Chemical Fixes Cystic Fibrosis Defect, McGill University Study     10/29/2012
Differences Seen in Lung Microbes of Cystic Fibrosis Patients, Stanford University Study     10/1/2012
Big Advance Against Cystic Fibrosis: Stem Cell Researchers Create Lung Surface Tissue in a Dish, Massachusetts General Hospital Study     4/6/2012
Student, 16, Invents New Drug Cocktail to Fight Cystic Fibrosis, Wins Canadian Biotech Challenge, National Research Council of Canada laboratories Reveals     5/12/2011
Cystic Fibrosis Patients May Benefit From Combination Therapy Which Provides Hope For Cure Of Dangerous Infections, McMaster University Study     4/25/2011

Press Releases
Vertex (VRTX) Gains Nearly $4 Billion In Market Cap As New Cystic Fibrosis Drug Wows In Two Phase III Studies     3/29/2017
Cystic Fibrosis Research Assays Are The Latest Additions To Canon BioMedical's Novallele Genotyping Library     3/7/2017
Mast Therapeutics (MSTX) Announces Clinical Study Of AIR001 For The Treatment Of Chronic Infection In Cystic Fibrosis Patients     3/6/2017
Vertex (VRTX) To Acquire CTP-656 From Concert Pharma (CNCE) For The Treatment Of Cystic Fibrosis     3/6/2017
PTC Therapeutics (PTCT) Ditches Cystic Fibrosis Drug After Trial Failure     3/2/2017
PTC Therapeutics (PTCT) Announces Results From Pivotal Phase III Clinical Trial Of Ataluren In Patients Living With Nonsense Mutation Cystic Fibrosis     3/2/2017
Galapagos (GLPG.BR) Doses First Healthy Volunteer With CF Combo GLPG2222 And GLPG2451     2/24/2017
Corbus (CRBP) Announces Preclinical Data Demonstrating JBT-101 Reduces Inflammation In Alveolar Macrophages From Cystic Fibrosis Patients     2/24/2017
Spyryx Biosciences Announces Successful Completion Of Phase 1 Clinical Trial For SPX-101 And Planned Phase 2 Initiation In Cystic Fibrosis During 2017     2/6/2017
Concert Pharmaceuticals, Inc. (CNCE) Release: Biopharma Receives FDA Orphan Drug Designation For CTP-656 For The Treatment Of Cystic Fibrosis     1/20/2017
Concert Pharmaceuticals, Inc. (CNCE) Release: Company Provides Further Details On CTP-656 Development In U.S. And Europe     1/17/2017
Portable Genomics Release: Company And Have Entered Into A Partnership To Enable Cystic Fibrosis Patients To Better Collect, Manage And Share Important Biometrics With Caregivers, Researchers And The Pharmaceutical Industry     1/17/2017
HUB And Dutch Health Insurance Companies To Validate Use Of Organoids For Cystic Fibrosis     1/6/2017
Catabasis (CATB) Research On CAT-5571, A Novel Activator Of Autophagy And Potential Oral Treatment For Cystic Fibrosis, Published In Journal Of Medicinal Chemistry     1/5/2017
Concert Pharmaceuticals, Inc. (CNCE) Initiates Phase 2 Clinical Trial Evaluating CTP-656 For The Treatment Of Cystic Fibrosis     12/21/2016